| Patents for C07J 43 - Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,516) |
|---|
| 11/30/2006 | CA2609726A1 17.beta.-hsd1 and sts inhibitors |
| 11/22/2006 | EP1724254A2 Novel compositions for the delivery of negatively charged molecules |
| 11/22/2006 | CN1867577A Estratriene derivatives |
| 11/21/2006 | US7138517 Sugar modified oligonucleotides |
| 11/21/2006 | US7138390 3 alpha ,7 alpha -dihydroxy-6 alpha -ethyl-5 beta -cholan-24-oic acid and salts, solvates or amino acid conjugates thereof; treatment of a farnesoid X receptor mediated disease such as hypercholesteremia, hyperlipidemia, low HDL-cholesterol, and high triglycerides |
| 11/14/2006 | CA2258681C Process for the preparation of 17-esters of 9.alpha.,21-dihalo-pregnane-11.beta.,17.alpha.diol-20-ones |
| 11/02/2006 | US20060247219 Specific glucocorticosteriod compound having anti-inflamatory activity |
| 11/02/2006 | US20060247216 Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments |
| 11/01/2006 | CN1853722A Methods for preventing antipsychotic-induced weight gain |
| 10/05/2006 | US20060223784 Method and compositions for temporarily incapacitating subjects |
| 10/05/2006 | US20060223076 Cyanine dyes and their applications as luminescence quenching compounds |
| 09/26/2006 | US7112580 3-nitrogen-6, 7-dioxygen steroids and uses related thereto |
| 09/08/2006 | WO2006093993A1 Novel c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity |
| 09/08/2006 | CA2599953A1 Novel c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity |
| 09/06/2006 | CN1829731A Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis-regulating medicaments and method for the preparation thereof |
| 09/05/2006 | US7101993 Oligonucleotides containing 2′-O-modified purines |
| 09/05/2006 | US7101866 6,9-Difluoro-17 alpha -((2-furanylcarbonyl)oxy)-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; antiinflammatory agents for the treatment of allergic conditions |
| 08/30/2006 | EP1322660B1 17alpha-fluoroalkyl steroids, method for producing the same and pharmaceutical compositions containing said compounds |
| 08/24/2006 | WO2006032885A3 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 08/16/2006 | CN1269836C Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 08/15/2006 | US7091187 Using steroid; autoimmune disease |
| 07/26/2006 | EP1082338B1 17 beta-nitro-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/20/2006 | US20060160781 A conjugated compound with triamcinolone acetonide; Antiinflammatory agents; immunosuppressants |
| 07/20/2006 | US20060160780 A conjugated compound with prednicarbate; Antiinflammatory agents; immunosuppressants |
| 07/19/2006 | EP1082337B1 17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/19/2006 | CN1803826A Method for preparing steroid muscular relaxant and analogue thereof |
| 07/13/2006 | US20060154905 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 07/11/2006 | US7074778 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 07/11/2006 | CA2090584C Steroids having a methylene lactone group at position 17, process for preparing the same and their intermediates, use of the same as drugs and pharmaceutical compositions comprising the same |
| 07/06/2006 | WO2006046123A3 Conjugates with anti-inflammatory activity |
| 07/06/2006 | US20060149045 Steroid compounds with anti-tumor activity |
| 07/06/2006 | US20060148773 Therapy for hormone sensitive diseases; side effect reduction; anticancer agents; benign prostatic hyperplasa; cardiovascular disorders; acne |
| 06/27/2006 | US7067503 17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 06/21/2006 | CN1791610A Oestrogen derivatives as inhibitors of steroid sulphatase. |
| 06/14/2006 | CN1259365C High friction coefficient rubber composite brake shoes |
| 06/07/2006 | EP1664079A1 Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis-regulating medicaments and method for the preparation thereof |
| 05/30/2006 | CA2085831C Polymers and oligomers of bile acid derivatives, process for their preparation and their use as pharmaceuticals |
| 05/23/2006 | US7049326 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/23/2006 | US7049305 Bile-acid conjugates providing for sustained systemic concentration of drugs |
| 05/16/2006 | US7045606 Chelate compound containing ligand with steroids, enzymes, hapten and antibodies |
| 05/09/2006 | US7041839 Therapy for hormone sensitivity disease; side effect reduction; anticancer agents |
| 05/04/2006 | WO2006046123A2 Conjugates with anti-inflammatory activity |
| 05/04/2006 | US20060094696 Oestrogen derivatives as inhibitors of steroid sulphatase |
| 05/04/2006 | CA2585711A1 Conjugates with anti-inflammatory activity |
| 05/02/2006 | US7038050 Method for the preparation of highly pure 1-androstene derivatives |
| 05/02/2006 | US7038041 Selective nuclear receptor-targeted systems for delivery of cytotoxins to cancer cells for targeted photodynamic therapy |
| 04/19/2006 | EP1646640A1 Method for the preparation of highly pure 1-androstene derivatives |
| 04/13/2006 | WO2006038047A1 Environment-friend process for the synthesis of quaternary ammonio-steroιds |
| 04/13/2006 | US20060079702 Process for making estra-4,9(10)-diene steroids |
| 04/12/2006 | EP0912179B1 Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors |
| 04/06/2006 | WO2008034796A2 Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors |
| 04/06/2006 | US20060074059 Isomorphic crystalline habits of 3alpha-hydroxy-21-(1'-imidazolyl)-3beta-methoxymethyl-5alpha-pregnane-20-one |
| 03/30/2006 | WO2006032885A2 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 03/30/2006 | CA2576614A1 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 03/28/2006 | US7018994 Antiestrogen compound |
| 03/28/2006 | US7018991 A hormonal or antihormonal steroid compound of structure I, amines or amine oxides |
| 03/23/2006 | US20060063747 Paroxetine cholate or cholic acid derivative salts, and composition comprising paroxetine and cholic acid or derivative thereof |
| 03/23/2006 | US20060063746 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators |
| 03/09/2006 | US20060052594 New corticosteroids |
| 03/08/2006 | EP1404717A4 Kinetic assay |
| 03/02/2006 | WO2006021776A1 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 03/02/2006 | CA2576922A1 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 02/22/2006 | EP0549615B1 Sugar modified oligonucleotides that detect and modulate gene expression |
| 02/15/2006 | EP1625143A1 Estratriene derivatives |
| 02/09/2006 | US20060030551 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 02/08/2006 | EP1622926A2 Novel method and intermediates for the preparation of 19-nor-steroids-17-halogen compounds |
| 02/02/2006 | WO2005105822A3 3-alpha-hydroxy 21-n- heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof |
| 02/02/2006 | WO2005068487A3 Processes for the preparation of rocuronium bromide and intermediates thereof |
| 02/01/2006 | EP1169336B1 Ent-steroids as selectively active estrogens |
| 01/25/2006 | EP1618122A1 Synthesis of solanum glycosides |
| 01/24/2006 | CA2151561C Hydrazino and hydroxyamino-14.beta.-hydroxyandrostane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
| 01/12/2006 | US20060009436 11 beta -Fluoro-7 alpha -{5-[methyl(7,7,8,8,9,9,9-heptafluorononyl)amino]pentyl}-17 alpha -methylestra-1,3,5(10)-triene-3,17 beta -diol N-oxide; antiestrogen compound whose metabolism can be controlled; alveolar macrophages do not build up; oral administration |
| 01/12/2006 | US20060009431 Nitrosated and nitrosylated compounds, compositions and methods use |
| 01/10/2006 | US6984634 For prophylaxis and therapy |
| 01/10/2006 | CA2425841C Angiostatic steroids |
| 01/05/2006 | US20060003976 Cholesterol/bile acid/bile acid derivative-modified therapeutic drug compounds |
| 12/28/2005 | EP1608671A1 Oestrogen derivatives as inhibitors of steroid sulphatase |
| 12/15/2005 | WO2005118612A1 Cholesterol/bile acid/bile acid derivative-modified therapeutic anti-cancer drugs |
| 12/14/2005 | EP1603933A2 Nitrosated and nitrosylated compounds, compositions and methods of use |
| 12/14/2005 | CN1231493C Amphoteric sterols and the use thereof |
| 11/29/2005 | CA2123048C Tetrazole derivatives of bile acids, processes for their preparation and the use of these compounds as medicaments |
| 11/16/2005 | CN1227259C Propanolamine derivs. linked with bile acid used for treating disorders of lipid metabolism |
| 11/10/2005 | WO2005105822A2 3-alpha-hydroxy 21-n- heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof |
| 11/09/2005 | EP1019365B1 Novel compositions for the delivery of negatively charged molecules |
| 11/09/2005 | CN1694896A Processes for preparing C-7 substituted 5-androstenes |
| 11/03/2005 | US20050245744 Method for the preparation of highly pure 1-androstene derivatives |
| 11/02/2005 | CN1692123A Compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 10/26/2005 | EP1587818A2 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators |
| 10/20/2005 | US20050234232 Novel compositions for the delivery of negatively charged molecules |
| 10/12/2005 | CN1680425A 6.alpha., 9.alpha.-difluoro-17.alpha.-'(2-furanylcaboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1, 4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflamatory agent |
| 10/12/2005 | CN1680423A Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 10/11/2005 | US6953785 Estra-1,3,5(10)-triene derivatives |
| 10/06/2005 | WO2005092912A1 Progesterone receptor modulators |
| 10/06/2005 | US20050222098 Regulation of meiosis |
| 10/06/2005 | US20050222097 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity |
| 09/29/2005 | US20050215534 Antiinflammatory agents; asthma; chronic obstructive pulmonary disease; dermatitis; antiallergens; antitumor agents; Aida; antiischemic agents; arrhythmia |
| 09/07/2005 | EP1569658A2 Treatment of ebv and khsv infection and associated abnormal cellular proliferation |
| 09/07/2005 | CN1665831A Novel compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 08/31/2005 | EP1392714B1 Steroids as agonists for fxr |
| 08/24/2005 | EP1565192A2 Method and compositions for temporarily incapaciting subjets |